Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 5;105(11):791-801.
doi: 10.1093/jnci/djt073. Epub 2013 Apr 19.

Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance

Patricia A Ganz  1 , Lorna Kwan, Steven A Castellon, Amy Oppenheim, Julienne E Bower, Daniel H S Silverman, Steve W Cole, Michael R Irwin, Sonia Ancoli-Israel, Thomas R Belin
Affiliations

Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance

Patricia A Ganz et al. J Natl Cancer Inst. .

Abstract

Background: Cognitive complaints are reported frequently after breast cancer treatments. Their association with neuropsychological (NP) test performance is not well-established.

Methods: Early-stage, posttreatment breast cancer patients were enrolled in a prospective, longitudinal, cohort study prior to starting endocrine therapy. Evaluation included an NP test battery and self-report questionnaires assessing symptoms, including cognitive complaints. Multivariable regression models assessed associations among cognitive complaints, mood, treatment exposures, and NP test performance.

Results: One hundred eighty-nine breast cancer patients, aged 21-65 years, completed the evaluation; 23.3% endorsed higher memory complaints and 19.0% reported higher executive function complaints (>1 SD above the mean for healthy control sample). Regression modeling demonstrated a statistically significant association of higher memory complaints with combined chemotherapy and radiation treatments (P = .01), poorer NP verbal memory performance (P = .02), and higher depressive symptoms (P < .001), controlling for age and IQ. For executive functioning complaints, multivariable modeling controlling for age, IQ, and other confounds demonstrated statistically significant associations with better NP visual memory performance (P = .03) and higher depressive symptoms (P < .001), whereas combined chemotherapy and radiation treatment (P = .05) approached statistical significance.

Conclusions: About one in five post-adjuvant treatment breast cancer patients had elevated memory and/or executive function complaints that were statistically significantly associated with domain-specific NP test performances and depressive symptoms; combined chemotherapy and radiation treatment was also statistically significantly associated with memory complaints. These results and other emerging studies suggest that subjective cognitive complaints in part reflect objective NP performance, although their etiology and biology appear to be multifactorial, motivating further transdisciplinary research.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overview of the UCLA Mind Body Study, a prospective longitudinal cohort study designed to examine the impact of endocrine therapy for breast cancer on cognitive functioning. DX = breast cancer diagnosis; NP = neuropsychological; PET = positron emission tomography; rx = treatment.
Figure 2.
Figure 2.
CONSORT flow chart of recruitment and screening for the study.
See this image and copyright information in PMC

Comment in

References

    1. Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology (Wiliston Park). 2000; 14(1):75–79 - PubMed
    1. Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol. 1994; 12(12):2621–2629 - PubMed
    1. Meyers CA. How chemotherapy damages the central nervous system. J Biol. 2008; 7(4):11 - PMC - PubMed
    1. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008; 18(2):121–131 - PubMed
    1. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002; 20(2):485–493 - PubMed

Publication types

MeSH terms

Substances